Skip to search formSkip to main contentSkip to account menu

hu1124

Known as: Hu 1124 
National Institutes of Health

Related topics

Related topics

1 relation
efalizumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Efalizumab for the Treatment of Moderate to Severe Plaque Psoriasis
OBJECTIVE: To review the pharmacology, efficacy, and safety of efalizumab for the treatment of moderate to severe plaque… 
Review
2002
Review
2002
Efalizumab. Anti-CD11a monoclonal antibody--Genentech/Xoma, HU 1124, hu1124, xanelim.
Review
2001
Review
2001
The role of newer monoclonal antibodies in renal transplantation.
2000
2000
hu1124 (Genentech).
  • H. Granlund
  • IDrugs : the investigational drugs journal
  • 2000
  • Corpus ID: 10234921
Genentech and XOMA are collaborating in the development of a humanized monoclonal antibody, hu1124 (anti-CD11a), which has the… 
2000
2000
Hu1124 improves psoriasis
  • 2000
  • Corpus ID: 195131707
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)